A detailed history of New Hampshire Trust transactions in Eli Lilly & CO stock. As of the latest transaction made, New Hampshire Trust holds 714 shares of LLY stock, worth $653,002. This represents 0.13% of its overall portfolio holdings.

Number of Shares
714
Previous 686 4.08%
Holding current value
$653,002
Previous $400 Million 38.91%
% of portfolio
0.13%
Previous 0.1%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 09, 2024

BUY
$592.2 - $792.28 $16,581 - $22,183
28 Added 4.08%
714 $555 Million
Q4 2023

Jan 12, 2024

BUY
$525.19 - $619.13 $92,958 - $109,586
177 Added 34.77%
686 $400 Million
Q3 2023

Oct 17, 2023

SELL
$434.7 - $599.3 $26,516 - $36,557
-61 Reduced 10.7%
509 $273 Million
Q2 2023

Jul 11, 2023

BUY
$350.74 - $468.98 $2,104 - $2,813
6 Added 1.06%
570 $267 Million
Q1 2023

Apr 18, 2023

SELL
$310.63 - $364.82 $23,607 - $27,726
-76 Reduced 11.88%
564 $194 Million
Q4 2022

Feb 09, 2023

BUY
$321.55 - $374.67 $205,792 - $239,788
640 New
640 $234 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track New Hampshire Trust Portfolio

Follow New Hampshire Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Hampshire Trust, based on Form 13F filings with the SEC.

News

Stay updated on New Hampshire Trust with notifications on news.